Global Needle-Free Injection Systems Market Size study & Forecast, by Product (Fillable, Prefilled), By Source of Power (Spring-based Injector Systems, Gas Propelled/Air Forced Injector Systems), By Type (Liquid-based, Projectile/Depot-based, Powder-based

Global Needle-Free Injection Systems Market Size study & Forecast, by Product (Fillable, Prefilled), By Source of Power (Spring-based Injector Systems, Gas Propelled/Air Forced Injector Systems), By Type (Liquid-based, Projectile/Depot-based, Powder-based), By Usability (Disposable, Reusable), By Site of Delivery (Subcutaneous Injectors, Injectors Intradermal Injectors), By Application (Vaccine Delivery, Insulin Delivery, Pain Management, Others), By End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Others), and Regional Analysis, 2023-2030

Global Needle-Free Injection Systems Market is valued approximately USD 156 million in 2022 and is anticipated to grow with a healthy growth rate of more than 20% over the forecast period 2023-2030. Needle-free injection systems are utilized for delivering liquid formulations, medications, and vaccines to patients without the use of traditional needles that pierce the skin. The demand for these systems has significantly risen in recent years due to their ability to enhance immune responses to vaccines, mitigate needle-related risks, and lower healthcare expenses. The market growth is driven by key factors such as growing Prevalence of Patients and Promote Treatment, rising expenditure for research and development, and rise in prevalence of diabetes.

Drugs are intended to be administered into the body most conveniently and painlessly possible, without the use of injection needles. Needle-free injection systems are employed for delivering medications to treat various conditions. It is projected that the value of the needle-free injection system market will rise over the forecasted period, driven by the growing prevalence of chronic diseases such as osteoporosis and diabetes. For instance, in 2022, the United States recorded over 33.7 million hospital admissions. Despite a decline in the number of hospitals in recent years, the country is witnessing a rise in its elderly population. As anticipated, the elderly constitute the largest demographic among hospital admissions in the U.S. Also, Hospital stays are more prevalent among females than males, with approximately 7.2 percent of females reporting one or more hospital stays in the past year, compared to 4.8 percent of males. Additionally, 16.6 percent of individuals aged 65 years and older experienced hospitalization in the past year, in contrast to only 6.6 percent of those aged 18 to 44 years. On average, a hospital stay in the United States lasts for 5.7 days. However, the lack of skilled professionals and restricted use of needle-free injection systems for intravenous administration stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Needle-Free Injection Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the Global Needle-Free Injection Systems Market, supported by robust healthcare infrastructure, the prominent presence of key market players, escalating cases of chronic diseases, and a surge in research endeavors within the region.

Meanwhile, the Asia-Pacific region is expected to be the fastest growing region from 2023 to 2030. This growth can be attributed to increased government initiatives aimed at raising awareness, expanding research activities, access to vast untapped markets, a large population base, and growing demand for quality healthcare services across the region.

Major market player included in this report are:
NuGen Medical Devices (Canada)
PharmaJet (U.S.)
Portal Instruments (U.S.)
Medical International Technology, Inc (U.S.)
Crossject SA (U.S.)
Antares Pharma (U.S.)
3M (U.S.)
Injex Pharma AG (Germany)
NovaXS Biotech (U.S.)
INVIO Pharmaceutical Inc. (U.S.)

Recent Developments in the Market:
 In October 2022, Science - Link Trading, a company dedicated to facilitating the commercialization of emerging disruptive technologies, entered into a distributorship agreement with NuGen Medical Devices Inc., a trailblazer in needle-free medicine delivery. The agreement outlines the purchase of 34,000 InsuJet devices over a span of five years, along with additional accessories.
 In June 2022, NovaXS Biotech unveiled the latest prototype of its innovative smart medical device for needle-free injectable therapy. Named Telosis, this patent-pending device from NovaXS delivers medication through a narrow stream in just 0.3 seconds, eliminating the need for needles. Furthermore, Telosis evaluates injection data to enable informed medical decisions.

Global Needle-Free Injection Systems Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product, Source of Power, Type, Usability, Site of Delivery, Application, End-user, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Fillable
Prefilled
By Source of Power:
Spring-based Injector Systems
Gas Propelled/Air Forced Injector Systems
By Type:
Liquid-based
Projectile/Depot-based
Powder-based
By Usability:
Disposable
Reusable
By Site of Delivery:
Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors
By Application:
Vaccine Delivery
Insulin Delivery
Pain Management
Others
By End User:
Hospitals & Clinics
Home Care Settings
Research Laboratories
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.